Follow-up, Chemotherapy, Radiotherapy

In a review of over 1,630,000 office-based non-breast imaging Medicare fee-for-service (FFS) claims from 2022, researchers found that 39.5 percent of nuclear medicine imaging were interpreted by ordering clinicians.

Drs. Charles Liu and Jonathan Russin discuss the benefits and potential of fPACT, the alternative to functional MRI.

Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.

KA Imaging President and Chief Executive Officer Amol Karnick and Chief Technology Officer Karim S. Karim, Ph.D., offer insights into current X-ray imaging trends, as well as opportunities for innovation.

LI-RADS category 5 (LR-5) assessment had an 11 percent higher AUC for detecting hepatocellular carcinoma (HCC) in patients with non-cirrhotic chronic hepatitis C (CHC) in comparison to those with cirrhotic CHC.

The cLung-RADS v2022 model offered a greater than 16 percent increase in the AUC in comparison to Lung-RADS 1.0 and Lung-RADS v2022 systems for predicting the invasiveness of pure ground-glass nodules.